Siemens Lands First FDA OK’s On Tests To Estimate COVID-19 Blood Antibodies
Executive Summary
The tests shouldn’t be used as diagnostics, but will give researchers more information about the body’s COVID-19 response.
You may also be interested in...
Siemens Healthineers Adds Muscle To Global Antibody Testing Effort, In Talks With Vaccine Developers
The company now has US emergency use designation for its new SARS-CoV-2 test, which can run on its global installed base of 20,000 analyzers at a current capacity of 50 million tests per month.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.
FDA Leader Looks To International Effort On Pediatric Device Development
Collaboration with Japan and Europe could help ease the development path for pediatric devices, cardiovascular device office director Bram Zuckerman said at a recent conference. Zuckerman also spoke on other cardiac device priorities at the FDA.